|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Amedisys (NASDAQ: AMED) through any online brokerage.
The latest price target for Amedisys (NASDAQ: AMED) was reported by Benchmark on 2021-02-23. The analyst firm set a price target for 325.00 expecting AMED to rise to within 12 months (a possible 14.80% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Amedisys (NASDAQ: AMED) is $283.09 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Amedisys.
There is no upcoming split for Amedisys.